Source: Clinical and Experimental Immunology. Unidade: FMRP
Assunto: IMUNOLOGIA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DANTAS, Márcio et al. Intravenous immunoglobulin (IVIG) attenuates antobody biding in acute haemorrhagic immunopneumonities in a rat model of complement-depnedent lung injury. Clinical and Experimental Immunology, v. 121, p. 139-145, 2000Tradução . . Disponível em: https://doi.org/10.1046/j.1365-2249.2000.01252.x. Acesso em: 19 out. 2024.APA
Dantas, M., Costa, R. S., Barbosa, J. E., Graeff, M. S. Z., Sarti, W., & Carvalho, I. F. de. (2000). Intravenous immunoglobulin (IVIG) attenuates antobody biding in acute haemorrhagic immunopneumonities in a rat model of complement-depnedent lung injury. Clinical and Experimental Immunology, 121, 139-145. doi:10.1046/j.1365-2249.2000.01252.xNLM
Dantas M, Costa RS, Barbosa JE, Graeff MSZ, Sarti W, Carvalho IF de. Intravenous immunoglobulin (IVIG) attenuates antobody biding in acute haemorrhagic immunopneumonities in a rat model of complement-depnedent lung injury [Internet]. Clinical and Experimental Immunology. 2000 ; 121 139-145.[citado 2024 out. 19 ] Available from: https://doi.org/10.1046/j.1365-2249.2000.01252.xVancouver
Dantas M, Costa RS, Barbosa JE, Graeff MSZ, Sarti W, Carvalho IF de. Intravenous immunoglobulin (IVIG) attenuates antobody biding in acute haemorrhagic immunopneumonities in a rat model of complement-depnedent lung injury [Internet]. Clinical and Experimental Immunology. 2000 ; 121 139-145.[citado 2024 out. 19 ] Available from: https://doi.org/10.1046/j.1365-2249.2000.01252.x
